Similarly, CXCR2 (C-X-C chemokine receptor type 2), which is often overexpressed in hepatocellular carcinoma (HCC) patients, has also been recognized as an indicator of poor prognosis in various cancers, including liver cancer [266]. This evidence concerns the gene CXCR2 and hepatocellular carcinoma.